Female member of staff using mammogram machine

Research at Barts Health

Our ambition is to offer every patient the opportunity to take part in research. 

International Clinical Trials Day

International Clinical Trials Day 2026

Every year on 20 May, we mark International Clinical Trials Day - the anniversary of James Lind's 1747 scurvy study, widely recognised as the world's first controlled clinical trial. It is a moment to thank the patients who take part in research and trials every year, recognise the many teams of staff who make it all possible, and reflect on the huge impact these advancements have on people's lives.

Note: This year's Research Matters event will take place in September 2026

Research Matters 2025

Research Matters, an annual event hosted by Barts Health NHS Trust to celebrate International Clinical Trials Day, took place on Tuesday 20 May 2025. The theme was Artificial Intelligence (AI) in Healthcare and highlighted the groundbreaking work happening across Barts Health and Queen Mary University of London. 

Our research strategy

Our ambitious research strategy aims to build on our existing strengths in areas of research like cardiovascular disease and cancer, and to drive improvements and develop other areas of work like precision medicine. Projects we’re working on include: 

  • increasing research funding and recruitment to clinical trials from our local, diverse populations to ensure our research is representative and will benefit everyone. One way we’re doing this is by collaborating with the Genes & Health programme
  • building on our existing work in specialities such as cancer, trauma, metabolic disease and population health, including women’s health by building on the success of our NIHR Barts Biomedical Research Centre and the Barts Cancer Institute.
  • building our research infrastructure through the development of a clinical research facility at The Royal London Hospital and the development of a life sciences campus at Whitechapel.
  • expanding our research portfolio of early phase clinical trials, supported in part by the NIHR Clinical Research Facility infrastructure programme
  • identifying new opportunities to strengthen reserach in areas such as gestational diabetes and older people’s services
  • ensuring our research influences and helps support the redesign of the services we provide, to drive improvements in patient care and outcomes, like we have achieved in trauma care.

Our partners

We work with other organisations to deliver our research strategy, and to ensure that people and patients have access to as many research opportunities as possible. These include the:

We work very closely with the Joint Research Medical Office (JRMO). If you are a researcher or a member of staff with a question about research, the JMRO are always on hand to help out - either contact them centrally or contact a specific individual

Contact us

Get in touch

Whatever your question, please do get in touch.

Whether you have questions about taking part in research, want to know how you can help shape our research, need to know more about carrying out research or anything else, we're here to help.  

Email the research engagement team 

If you are a researcher or a member of staff with a question about research, please the Joint Management Research Office (JMRO)

Contact the JMRO

To keep up-to-date with all our latest research, follow us on X.

Follow us

       

Research at Barts Health

image-Barts Cancer Centre.jpg
Barts Health patients set to benefit from new life-extending drug for ovarian cancer

A new drug that extends survival for women with hard-to-treat ovarian cancer is now available on the NHS. The treatment was tested at St Bartholomew's Hospital as part of a major global clinical trial…

Read Barts Health patient …
image-Data.jpg
Now live: Barts Health Data Platform

The Barts Health Data Platform is now live, providing secure, large-scale data access to support research, innovation, and improved patient outcomes. Whether you are an academic, clinician, pharmaceu…

Read Now live: Barts Heal …
Image of Daniel Cullinane
Promising gene editing therapy lowers ‘bad’ cholesterol

A new therapy, called VERVE-102, is a one-off infusion, using gene editing to switch off the gene that tells the liver to make a protein called PCSK9.…

Read Promising gene editi …
image-Antoinette, Eden and Raffy_HARMONIE_1.jpg
Changing lives through clinical trials

On International Clinical Trials Day, we revisit the stories of three patients who took part in clinical trials impacting the future of medicine.…

Read Changing lives throu …
image-CTP_Launch_Apr_26_7.jpg
Newham residents set to benefit from new specialised pharmacy

The new Clinical Trials Pharmacy has  been unveiled this week at Newham Hospital, providing the infrastructure needed to run pioneering clinical trials directly on site and offer greater local ac…

Read Newham residents set …